Table 1. Global Opioids Market, by Product Type, 2020-2030 ($Million)
Table 2. Global Opioids Market for Fentanyl, by Region, 2020-2030 ($Million)
Table 3. Global Opioids Market for Oxycodone, by Region, 2020-2030 ($Million)
Table 4. Global Opioids Market for Methadone, by Region, 2020-2030 ($Million)
Table 5. Global Opioids Market for Morphine, by Region, 2020-2030 ($Million)
Table 6. Global Opioids Market for Hydrocodone, by Region, 2020-2030 ($Million)
Table 7. Global Opioids Market for Others, by Region, 2020-2030 ($Million)
Table 8. Global Opioids Market, by Application, 2020-2030 ($Million)
Table 9. Global Opioids Market for Pain Management, by Region, 2020-2030 ($Million)
Table 10. Global Opioids Market for Cough Treatment, by Region, 2020-2030 ($Million)
Table 11. Global Opioids Market for Diarrhea Treatment, by Region, 2020-2030 ($Million)
Table 12. Global Opioids Market, by Region, 2020-2030 ($Million)
Table 13. North America Opioids, by Product Type, 2020-2030 ($Million)
Table 14. North America Opioids, by Application, 2020-2030 ($Million)
Table 15. U.S Opioids, by Product Type, 2020-2030 ($Million)
Table 16. U.S Opioids, by Application, 2020-2030 ($Million)
Table 17. Canada Opioids, by Product Type, 2020-2030 ($Million)
Table 18. Canada Opioids, by Application, 2020-2030 ($Million)
Table 19. Mexico Opioids, by Product Type, 2020-2030 ($Million)
Table 20. Mexico Opioids, by Application, 2020-2030 ($Million)
Table 21. Europe Opioids, by Product Type, 2020-2030 ($Million)
Table 22. Europe Opioids, by Application, 2020-2030 ($Million)
Table 23. Germany Opioids, by Product Type, 2020-2030 ($Million)
Table 24. Germany Opioids, by Application, 2020-2030 ($Million)
Table 25. France Opioids, by Product Type, 2020-2030 ($Million)
Table 26. France Opioids, by Application, 2020-2030 ($Million)
Table 27. Uk Opioids, by Product Type, 2020-2030 ($Million)
Table 28. Uk Opioids, by Application, 2020-2030 ($Million)
Table 29. Italy Opioids, by Product Type, 2020-2030 ($Million)
Table 30. Italy Opioids, by Application, 2020-2030 ($Million)
Table 31. Spain Opioids, by Product Type, 2020-2030 ($Million)
Table 32. Spain Opioids, by Application, 2020-2030 ($Million)
Table 33. Rest of Europe Opioids, by Product Type, 2020-2030 ($Million)
Table 34. Rest of Europe Opioids, by Application, 2020-2030 ($Million)
Table 35. Asia-Pacific Opioids, by Product Type, 2020-2030 ($Million)
Table 36. Asia-Pacific Opioids, by Application, 2020-2030 ($Million)
Table 37. Japan Opioids, by Product Type, 2020-2030 ($Million)
Table 38. Japan Opioids, by Application, 2020-2030 ($Million)
Table 39. China Opioids, by Product Type, 2020-2030 ($Million)
Table 40. China Opioids, by Application, 2020-2030 ($Million)
Table 41. Australia Opioids, by Product Type, 2020-2030 ($Million)
Table 42. Australia Opioids, by Application, 2020-2030 ($Million)
Table 43. India Opioids, by Product Type, 2020-2030 ($Million)
Table 44. India Opioids, by Application, 2020-2030 ($Million)
Table 45. South Korea Opioids, by Product Type, 2020-2030 ($Million)
Table 46. South Korea Opioids, by Application, 2020-2030 ($Million)
Table 47. Rest of Asia-Pacific Opioids, by Product Type, 2020-2030 ($Million)
Table 48. Rest of Asia-Pacific Opioids, by Application, 2020-2030 ($Million)
Table 49. Lamea Opioids, by Product Type, 2020-2030 ($Million)
Table 50. Lamea Opioids, by Application, 2020-2030 ($Million)
Table 51. Brazil Opioids, by Product Type, 2020-2030 ($Million)
Table 52. Brazil Opioids, by Application, 2020-2030 ($Million)
Table 53. Saudi Arabia Opioids, by Product Type, 2020-2030 ($Million)
Table 54. Saudi Arabia Opioids, by Application, 2020-2030 ($Million)
Table 55. South Africa Opioids, by Product Type, 2020-2030 ($Million)
Table 56. South Africa Opioids, by Application, 2020-2030 ($Million)
Table 57. Rest of LAMEA Opioids, by Product Type, 2020-2030 ($Million)
Table 58. Rest of LAMEA Opioids, by Application, 2020-2030 ($Million)
Table 59. Boehringer Ingelheim Group: Key Executives
Table 60. Boehringer Ingelheim Group: Company Snapshot
Table 61. Boehringer Ingelheim Group: Operating Segments
Table 62. Boehringer Ingelheim Group: Product Portfolio
Table 63. Boehringer Ingelheim Group: Key Strategic Moves and Developments
Table 64. Astrazeneca plc: Key Executives
Table 65. Astrazeneca plc: Company Snapshot
Table 66. Astrazeneca plc: Operating Segments
Table 67. Astrazeneca plc: Product Portfolio
Table 68. Astrazeneca plc: Key Strategic Moves and Developments
Table 69. Endo Pharmaceuticals, Inc: Key Executives
Table 70. Endo Pharmaceuticals, Inc: Company Snapshot
Table 71. Endo Pharmaceuticals, Inc: Operating Segments
Table 72. Endo Pharmaceuticals, Inc: Product Portfolio
Table 73. Endo Pharmaceuticals, Inc: Key Strategic Moves and Developments
Table 74. Johnson and Johnson: Key Executives
Table 75. Johnson and Johnson: Company Snapshot
Table 76. Johnson and Johnson: Operating Segments
Table 77. Johnson and Johnson: Product Portfolio
Table 78. Johnson and Johnson: Key Strategic Moves and Developments
Table 79. Mallinckrodt plc: Key Executives
Table 80. Mallinckrodt plc: Company Snapshot
Table 81. Mallinckrodt plc: Operating Segments
Table 82. Mallinckrodt plc: Product Portfolio
Table 83. Mallinckrodt plc: Key Strategic Moves and Developments
Table 84. Pfizer Inc: Key Executives
Table 85. Pfizer Inc: Company Snapshot
Table 86. Pfizer Inc: Operating Segments
Table 87. Pfizer Inc: Product Portfolio
Table 88. Pfizer Inc: Key Strategic Moves and Developments
Table 89. Purdue Pharma L. P: Key Executives
Table 90. Purdue Pharma L. P: Company Snapshot
Table 91. Purdue Pharma L. P: Operating Segments
Table 92. Purdue Pharma L. P: Product Portfolio
Table 93. Purdue Pharma L. P: Key Strategic Moves and Developments
Table 94. Sanofi: Key Executives
Table 95. Sanofi: Company Snapshot
Table 96. Sanofi: Operating Segments
Table 97. Sanofi: Product Portfolio
Table 98. Sanofi: Key Strategic Moves and Developments
Table 99. Sun Pharmaceutical Industries Ltd: Key Executives
Table 100. Sun Pharmaceutical Industries Ltd: Company Snapshot
Table 101. Sun Pharmaceutical Industries Ltd: Operating Segments
Table 102. Sun Pharmaceutical Industries Ltd: Product Portfolio
Table 103. Sun Pharmaceutical Industries Ltd: Key Strategic Moves and Developments
Table 104. Teva Pharmaceutical Industries Limited: Key Executives
Table 105. Teva Pharmaceutical Industries Limited: Company Snapshot
Table 106. Teva Pharmaceutical Industries Limited: Operating Segments
Table 107. Teva Pharmaceutical Industries Limited: Product Portfolio
Table 108. Teva Pharmaceutical Industries Limited: Key Strategic Moves and Developments

LIST OF FIGURE

Figure 1. Global Opioids Market Segmentation
Figure 2. Global Opioids Market
Figure 3. Segmentation Opioids Market
Figure 4. Top Investment Pocket in Opioids Market
Figure 5. Top Winning Strategies, 2019-2021*
Figure 6. Top Winning Strategies, by Development, 2019-2021(%)
Figure 7. Top Winning Strategies, by Company, 2019-2021*
Figure 8. Moderate Bargaining Power of Buyers
Figure 9. Moderate Bargaining Power of Suppliers
Figure 10. Moderate Threat of New Entrants
Figure 11. Low Threat of Substitution
Figure 12. High Competitive Rivalry
Figure 13. Top Player Positioning, 2020
Figure 14. Market Share Analysis, 2020
Figure 15. Restraints and Drivers: Opioids Market
Figure 16. Opioids Market Segmentation, by Product Type
Figure 17. Opioids Market for Fentanyl, by Country, 2020-2030 ($ Million)
Figure 18. Opioids Market for Oxycodone, by Country, 2020-2030 ($ Million)
Figure 19. Opioids Market for Methadone, by Country, 2020-2030 ($ Million)
Figure 20. Opioids Market for Morphine, by Country, 2020-2030 ($ Million)
Figure 21. Opioids Market for Hydrocodone, by Country, 2020-2030 ($ Million)
Figure 22. Opioids Market for Others, by Country, 2020-2030 ($ Million)
Figure 23. Opioids Market Segmentation, by Application
Figure 24. Opioids Market for Pain Management, by Country, 2020-2030 ($ Million)
Figure 25. Opioids Market for Cough Treatment, by Country, 2020-2030 ($ Million)
Figure 26. Opioids Market for Diarrhea Treatment, by Country, 2020-2030 ($ Million)
Figure 27. Boehringer Ingelheim Group: Net Sales, 2018-2020 ($ Million)
Figure 28. Boehringer Ingelheim Group: Revenue Share, by Segment, 2020 (%)
Figure 29. Boehringer Ingelheim Group: Revenue Share, by Region, 2020 (%)
Figure 30. Astrazeneca plc: Net Sales, 2018-2020 ($ Million)
Figure 31. Astrazeneca plc: Revenue Share, by Segment, 2020 (%)
Figure 32. Astrazeneca plc: Revenue Share, by Region, 2020 (%)
Figure 33. Endo Pharmaceuticals, Inc: Net Sales, 2018-2020 ($ Million)
Figure 34. Endo Pharmaceuticals, Inc: Revenue Share, by Segment, 2020 (%)
Figure 35. Endo Pharmaceuticals, Inc: Revenue Share, by Region, 2020 (%)
Figure 36. Johnson and Johnson: Net Sales, 2018-2020 ($ Million)
Figure 37. Johnson and Johnson: Revenue Share, by Segment, 2020 (%)
Figure 38. Johnson and Johnson: Revenue Share, by Region, 2020 (%)
Figure 39. Mallinckrodt plc: Net Sales, 2018-2020 ($ Million)
Figure 40. Mallinckrodt plc: Revenue Share, by Segment, 2020 (%)
Figure 41. Mallinckrodt plc: Revenue Share, by Region, 2020 (%)
Figure 42. Pfizer Inc: Net Sales, 2018-2020 ($ Million)
Figure 43. Pfizer Inc: Revenue Share, by Segment, 2020 (%)
Figure 44. Pfizer Inc: Revenue Share, by Region, 2020 (%)
Figure 45. Purdue Pharma L. P: Net Sales, 2018-2020 ($ Million)
Figure 46. Purdue Pharma L. P: Revenue Share, by Segment, 2020 (%)
Figure 47. Purdue Pharma L. P: Revenue Share, by Region, 2020 (%)
Figure 48. Sanofi: Net Sales, 2018-2020 ($ Million)
Figure 49. Sanofi: Revenue Share, by Segment, 2020 (%)
Figure 50. Sanofi: Revenue Share, by Region, 2020 (%)
Figure 51. Sun Pharmaceutical Industries Ltd: Net Sales, 2018-2020 ($ Million)
Figure 52. Sun Pharmaceutical Industries Ltd: Revenue Share, by Segment, 2020 (%)
Figure 53. Sun Pharmaceutical Industries Ltd: Revenue Share, by Region, 2020 (%)
Figure 54. Teva Pharmaceutical Industries Limited: Net Sales, 2018-2020 ($ Million)
Figure 55. Teva Pharmaceutical Industries Limited: Revenue Share, by Segment, 2020 (%)
Figure 56. Teva Pharmaceutical Industries Limited: Revenue Share, by Region, 2020 (%)